These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10807771)

  • 21. Common cytokine receptor gamma chain (gammac)-deficient B cells persist in T cell-deficient gammac-mice and respond to a T-independent antigen.
    Vosshenrich CA; Sharara LI; Guy-Grand D; Rajewsky K; Müller W; Di Santo JP
    Eur J Immunol; 2000 Jun; 30(6):1614-22. PubMed ID: 10898497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to the common gamma-chain as cytokine receptor antagonists in vivo: effect on intrathymic and intestinal intraepithelial T lymphocyte development.
    Malek TR; Levy RB; Adkins B; He YW
    J Leukoc Biol; 1998 Jun; 63(6):643-9. PubMed ID: 9620654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-cell-negative severe combined immunodeficiency associated with a common gamma chain mutation.
    Jones AM; Clark PA; Katz F; Genet S; McMahon C; Alterman L; Cant A; Kinnon C
    Hum Genet; 1997 May; 99(5):677-80. PubMed ID: 9150740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency.
    Yates F; Malassis-Séris M; Stockholm D; Bouneaud C; Larousserie F; Noguiez-Hellin P; Danos O; Kohn DB; Fischer A; de Villartay JP; Cavazzana-Calvo M
    Blood; 2002 Dec; 100(12):3942-9. PubMed ID: 12393742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.
    DiSanto JP; Rieux-Laucat F; Dautry-Varsat A; Fischer A; de Saint Basile G
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9466-70. PubMed ID: 7937790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
    Otsu M; Sugamura K; Candotti F
    Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity.
    Lagresle-Peyrou C; Yates F; Malassis-Séris M; Hue C; Morillon E; Garrigue A; Liu A; Hajdari P; Stockholm D; Danos O; Lemercier B; Gougeon ML; Rieux-Laucat F; de Villartay JP; Fischer A; Cavazzana-Calvo M
    Blood; 2006 Jan; 107(1):63-72. PubMed ID: 16174758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years.
    Leonard WJ
    Mol Med Today; 2000 Oct; 6(10):403-7. PubMed ID: 11006530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer.
    Bunting KD; Sangster MY; Ihle JN; Sorrentino BP
    Nat Med; 1998 Jan; 4(1):58-64. PubMed ID: 9427607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function.
    Hacein-Bey H; Cavazzana-Calvo M; Le Deist F; Dautry-Varsat A; Hivroz C; Rivière I; Danos O; Heard JM; Sugamura K; Fischer A; De Saint Basile G
    Blood; 1996 Apr; 87(8):3108-16. PubMed ID: 8605324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.
    Gaspar HB; Parsley KL; Howe S; King D; Gilmour KC; Sinclair J; Brouns G; Schmidt M; Von Kalle C; Barington T; Jakobsen MA; Christensen HO; Al Ghonaium A; White HN; Smith JL; Levinsky RJ; Ali RR; Kinnon C; Thrasher AJ
    Lancet; 2004 Dec 18-31; 364(9452):2181-7. PubMed ID: 15610804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
    Leonard WJ
    Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional alpha beta T cells are sufficient for innate and adaptive immunity against enteric Listeria monocytogenes.
    Bregenholt S; Berche P; Brombacher F; Di Santo JP
    J Immunol; 2001 Feb; 166(3):1871-6. PubMed ID: 11160234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
    Capo V; Castiello MC; Fontana E; Penna S; Bosticardo M; Draghici E; Poliani LP; Sergi Sergi L; Rigoni R; Cassani B; Zanussi M; Carrera P; Uva P; Dobbs K; Sacchetti N; Notarangelo LD; van Til NP; Wagemaker G; Villa A
    J Allergy Clin Immunol; 2018 Sep; 142(3):928-941.e8. PubMed ID: 29241731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
    White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
    Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.
    Felsburg PJ; Somberg RL; Hartnett BJ; Suter SF; Henthorn PS; Moore PF; Weinberg KI; Ochs HD
    Blood; 1997 Oct; 90(8):3214-21. PubMed ID: 9376605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.
    Clay TM; Custer MC; Spiess PJ; Nishimura MI
    Pathol Oncol Res; 1999; 5(1):3-15. PubMed ID: 10079371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.
    Ebeling P; Bach P; Sorg U; Schneider A; Trarbach T; Dilloo D; Hanenberg H; Niesert S; Seeber S; Moritz T; Flasshove M
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):199-209. PubMed ID: 17053889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.